Biofil Chemicals and Pharmaceuticals Ltd

Wed 2/09/2026,12:44:29 | NSE : BIOFILCHEM

₹31.69-0.46 (-1.43%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 32.60

Previous Close

₹ 32.15

Volume

2671

Mkt Cap ( ₹ Cr)

₹ 51.57

High

₹ 32.80

Low

₹ 31.55

52 Week High

₹ 46.34

52 Week Low

₹ 25.60

Book Value Per Share

₹ 13.32

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Biofil Chemicals and Pharmaceuticals Ltd

Your Vote -

Buy

39.06%

Hold

7.81%

Sell

53.13%

39.06%

64 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

49%

Sell Order Quantity

51%

Bid Price

Qty

31.66

66

32.00

2000

32.00

97

32.00

250

32.00

791

Bid Total

15581

Bid Price

Qty

31.95

6

32.00

80

32.00

57

32.00

22

32.00

966

Bid Total

16222

Option Chain

Analyzes market sentiment, predicts Biofil Chemicals and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Biofil Chem.&Pharma. - Copy of Newspaper Publication

    28 Aug 2026, 1:11PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI

  • Biofil Chem.&Pharma. Q1 net profit down 95.44% at Rs 0.11 cr

    26 Aug 2026, 6:00PM The company reported standalone net profit of Rs 0.11 crore for the quarter ended June 30, 2026 as compared to Rs 2.41 crore in the same period last y

  • Biofil Chem.&Pharma. - General Updates

    26 Aug 2026, 4:22PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about about intimation of e-voting for 41st Annual General Meeting

  • Biofil Chem.&Pharma. - General Updates

    26 Aug 2026, 4:07PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not register

  • Biofil Chem.&Pharma. - Shareholders meeting

    26 Aug 2026, 2:46PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

  • Biofil Chem.&Pharma. - Information Regarding E-Voting For 41St Annual General Meeting

    26 Aug 2026, 4:17PM Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 108 of the Companies Act, 2013

  • Biofil Chem.&Pharma. - Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With

    26 Aug 2026, 4:03PM Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ de

  • Biofil Chem.&Pharma. - Reg. 34 (1) Annual Report.

    26 Aug 2026, 2:10PM Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34

  • Biofil Chem.&Pharma. - Submission Of Notice Of Convening 41St AGM Of The Company.

    26 Aug 2026, 1:56PM Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio

  • Biofil Chem.&Pharma. - Copy of Newspaper Publication

    19 Aug 2026, 4:34PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 41st AGM through Video Conferenc

  • Biofil Chem.&Pharma. - Copy of Newspaper Publication

    12 Aug 2026, 12:50PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

  • Biofil Chem.&Pharma. - Change in Management

    11 Aug 2026, 6:39PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as

  • Biofil Chem.&Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    11 Aug 2026, 6:34PM Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company, notwithstanding his at

  • Biofil Chem.&Pharma. - Outcome of Board Meeting

    11 Aug 2026, 6:24PM Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Biofil Chem.&Pharma. - Un-Audited Financial Results For The Quarter Ended 30Th June 2026

    11 Aug 2026, 6:17PM Un-Audited Financial Results for the quarter ended 30th June 2026

  • Biofil Chem.&Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August, 2026 Pursuant To Regul

    11 Aug 2026, 6:09PM Outcome of Board Meeting held on Tuesday 11th August, 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulat

  • Biofil Chem.&Pharma. - Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company

    1 Aug 2026, 11:37AM Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter ali

  • Biofil Chem.&Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    16 Jul 2026, 7:40PM As of June 2026, 46.79% is owned by Indian Promoters and 53.21% by Public. <p align=justify> Top five Promoters holding highest number of shares of Bi

  • Biofil Chem.&Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    1 Jul 2026, 4:35PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Biofil Chem.&Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    1 Jul 2026, 4:29PM Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended

  • Biofil Chem.&Pharma. - Trading Window

    25 Jun 2026, 5:43PM Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tra
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Biofil Chemicals and Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 24.5843 19.2527 18.6417 17.8268 17.3024
Liabilities 24.5843 19.2527 18.6417 17.8268 17.3024
Equity 16.2738 16.2738 16.2738 16.2738 16.2738
Gross Profit 0.6494 0.8474 0.8165 1.1676 1.3327
Net Profit 2.7859 0.5577 0.7092 0.5604 0.6984
Cash From Operating Activities -0.6049 -1.9237 2.3937 -0.1118 -0.2199
NPM(%) 9.81 1.66 1.77 1.86 3.12
Revenue 28.3952 33.4022 40.0353 30.0352 22.3823
Expenses 27.7458 32.5548 39.2188 28.8676 21.0496
ROE(%) 12.85 2.57 3.27 2.58 3.22

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Biofil Chemicals and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 868.25 -0.40 21.96 18.39 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 108.00 -0.71 1542.86 67.01 0.39 0.00
Vaishali Pharma Ltd 8.24 2.62 25.75 420.35 15.42 0.00
Astec Lifesciences Ltd 571.20 1.56 0.00 71.79 -363.14 0.00

Company Info

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.

Parent Organisation

Biofil Chemicals & Pharmaceuticals Ltd.

Founded

04/01/1985

Managing Director

Mr.Ketan Shah

NSE Symbol

BIOFILCHEMEQ

FAQ